Lifevantage Corporation (LFVN)

Currency in USD
6.230
+0.240(+4.01%)
Closed·
6.240+0.010(+0.16%)
·
LFVN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.8856.230
52 wk Range
5.69027.380
Key Statistics
Prev. Close
5.99
Open
5.98
Day's Range
5.885-6.23
52 wk Range
5.69-27.38
Volume
162.13K
Average Volume (3m)
161.51K
1-Year Change
-61.9%
Book Value / Share
2.61
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LFVN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
14.500
Upside
+132.74%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Lifevantage Corporation News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Lifevantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.

Employees
235

Lifevantage Corporation Earnings Call Summary for Q1/2026

  • LifeVantage missed Q1 2026 forecasts with EPS of $0.18 (14.29% below expectations) and revenue of $47.63 million (15.1% below projections), causing shares to fall 4.22% to $7.03
  • Revenue increased marginally by 0.7% year-over-year, while adjusted EBITDA declined by $500,000 and gross margin decreased by 40 basis points to 79.5%
  • CEO Steve Fife emphasized creating a 'comprehensive wellness ecosystem' through innovation and community-building in the direct sales industry
  • The company projects FY2026 revenue between $225-240 million with adjusted EPS of $1.00-1.15, expecting stronger performance in H2 driven by LoveBiome integration
  • Strong performance in Japan offset modest growth in other markets, while integration of recent acquisitions presents both opportunities and operational challenges
Last Updated: 04/11/2025, 22:20
Read Full Transcript

Compare LFVN to Peers and Sector

Metrics to compare
LFVN
Peers
Sector
Relationship
P/E Ratio
7.8x18.9x11.8x
PEG Ratio
0.050.270.03
Price/Book
2.4x1.1x1.5x
Price / LTM Sales
0.3x1.3x0.9x
Upside (Analyst Target)
132.7%51.0%21.4%
Fair Value Upside
Unlock21.3%12.5%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 14.500
(+132.74% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Lake Street Capital Markets
Buy12.00+92.62%30.00Maintain05/11/2025
Craig-Hallum
Buy35.00+461.80%-New Coverage14/01/2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.78%
Dividend Yield
2.89%
Industry Median 2.50%
Annualised payout
0.18
Paid quarterly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Nov 04, 2025
EPS / Forecast
0.18 / 0.21
Revenue / Forecast
47.63M / 56.10M
EPS Revisions
Last 90 days

People Also Watch

3.550
DSWL
+5.34%
54.50
ECPG
-1.34%
4.070
SSP
+0.25%
40.81
CTRN
-5.14%
14.50
QNST
-1.23%

FAQ

What Is the Lifevantage (LFVN) Share Price Today?

The live Lifevantage share price today is 6.230

What Stock Exchange Does Lifevantage (LFVN) Trade On?

Lifevantage is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Lifevantage?

The stock symbol (also called a 'ticker') for Lifevantage is "LFVN."

Does Lifevantage Pay Dividends? What’s The Current LFVN Dividend Yield?

Yes, LFVN Pays Dividends to its Shareholders. The current Lifevantage dividend yield is 2.89%.

What Is the Current Lifevantage Market Cap?

As of today, Lifevantage market capitalisation is 79.13M.

What Is Lifevantage's (LFVN) Earnings Per Share (TTM)?

The Lifevantage EPS is currently 0.78 (Trailing Twelve Months).

When Is the Next Lifevantage Earnings Date?

Lifevantage's next earnings report will be released on 03 Feb 2026.

Is LFVN a Buy or Sell From a Technical Analyst Perspective?

Based on today's Lifevantage moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Lifevantage Stock Split?

Lifevantage has split 2 times. (See the LFVN stock split history page for full effective split date and price information.)

How Many Employees Does Lifevantage Have?

Lifevantage has 235 employees.

What is the current trading status of Lifevantage (LFVN)?

As of 24 Dec 2025, Lifevantage (LFVN) is trading at a price of 6.230, with a previous close of 5.990. The stock has fluctuated within a day range of 5.885 to 6.230, while its 52-week range spans from 5.690 to 27.380.

What Is Lifevantage (LFVN) Price Target According to Analysts?

The average 12-month price target for Lifevantage is USD14.5, with a high estimate of USD17 and a low estimate of USD12. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +132.74% Upside potential.

What Is the LFVN After Hours Price?

LFVN's last after hours stock price is 6.240, the stock has decreased by 0.010, or 0.160%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.